Fenimore Asset Management Inc purchased a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 125,008 shares of the company's stock, valued at approximately $9,259,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. N.E.W. Advisory Services LLC acquired a new position in GE HealthCare Technologies in the first quarter valued at $25,000. Bogart Wealth LLC raised its holdings in shares of GE HealthCare Technologies by 260.0% in the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company's stock worth $28,000 after purchasing an additional 247 shares during the period. Stonebridge Financial Group LLC lifted its stake in shares of GE HealthCare Technologies by 165.7% in the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock valued at $29,000 after purchasing an additional 222 shares in the last quarter. Olde Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies in the 1st quarter valued at about $35,000. Finally, Zions Bancorporation National Association UT purchased a new stake in shares of GE HealthCare Technologies during the 1st quarter worth about $42,000. Institutional investors and hedge funds own 82.06% of the company's stock.
GE HealthCare Technologies Trading Down 0.3%
Shares of NASDAQ GEHC opened at $76.56 on Monday. The company has a market cap of $34.95 billion, a price-to-earnings ratio of 15.69, a price-to-earnings-growth ratio of 2.93 and a beta of 1.13. The stock's 50 day simple moving average is $74.25 and its 200 day simple moving average is $72.48. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The company had revenue of $5 billion for the quarter, compared to analysts' expectations of $4.96 billion. During the same period last year, the business posted $1.00 earnings per share. The firm's quarterly revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Equities research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.
GE HealthCare Technologies Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies's payout ratio is 2.87%.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on GEHC. Weiss Ratings reiterated a "hold (c)" rating on shares of GE HealthCare Technologies in a research note on Saturday, September 27th. Citigroup upped their price target on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research report on Thursday, July 31st. BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Zacks Research lowered GE HealthCare Technologies from a "strong-buy" rating to a "hold" rating in a research report on Monday, September 29th. Finally, Morgan Stanley set a $74.00 target price on GE HealthCare Technologies in a research report on Thursday, September 18th. Seven research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies has a consensus rating of "Moderate Buy" and an average target price of $86.89.
Read Our Latest Stock Analysis on GEHC
About GE HealthCare Technologies
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
